Advanced Biomed Inc.
ADVB
$4.95
$0.4910.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.01% | -8.61% | 15.49% | 32.70% | -- |
| Total Depreciation and Amortization | -43.82% | -53.82% | -38.76% | 20.96% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -100.00% | -- |
| Change in Net Operating Assets | -1,585.79% | -1,103.09% | -1,222.04% | -210.91% | -- |
| Cash from Operations | -130.58% | -316.79% | -173.95% | -222.20% | -- |
| Capital Expenditure | 48.28% | 74.42% | 42.99% | 67.43% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 32.87% | 85.77% | 57.41% | 70.74% | -- |
| Total Debt Issued | -33.00% | -55.94% | -56.31% | -29.94% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 148.98% | 132.88% | 119.67% | 1,099.78% | -- |
| Cash from Financing | 230.92% | 207.76% | 217.89% | 601.35% | -- |
| Foreign Exchange rate Adjustments | -96.95% | 102.51% | -167.24% | -113.76% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.41% | -84.11% | 2,169.23% | 1,778.09% | -- |